| Phrase | Consultant | Town | Special Interests |
| clinical and pre-clinical drug development | *Consultant(s)* | *Towns* | Paediatric oncology, clinical and pre-clinical drug development, neuroblastoma |
development neuropsychiatry | *Consultant(s)* | *Towns* | Early onset psychoses, development neuropsychiatry, paediatric psychopharmacology, inpatient treatment in children |
development of Neurotrauma Services | *Consultant(s)* | *Towns* | Neurotrauma, head injuries, spine injuries, complex cranial neurosurgery, development of Neurotrauma Services, skull base surgery, neuroendoscopic procedures, management of complex CSF - cerebrospinal fluid disorders |
drug development | *Consultant(s)* | *Towns* | Gastrointestinal cancers, melanoma, drug development |
drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
gastrointestinal immunity and infections and vaccine development | *Consultant(s)* | *Towns* | IBD - inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastrointestinal immunity and infections and vaccine development, nutrition and irritable bowel syndrome - IBS, dyspepsia and reflux disease, feeding tube placement and nutrition, endoscopic ultrasound and laser therapy |
growth and development | *Consultant(s)* | *Towns* | Paediatric endocrinology, neuroendocrine and late effects of childhood malignancy, adolescence to 21yrs, growth and development, reproductive maturity, Turner's syndrome, congenital adrenal hyperplasia, short stature, paediatric endocrine oncology, pituitary tumours in childhood |
imaging in drug development | *Consultant(s)* | *Towns* | Diagnostic radiology, MRI, CT, oncology, functional MRI, imaging in drug development, prostate MRI |
new drug development | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, testicular cancer, new drug development, solid tumour cancers, ovarian cancer |
phase 1 drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, phase 1 drug development |
pituitary development | *Consultant(s)* | *Towns* | Paediatric endocrinology, pituitary development, septo-optic dysplasia |
service development and clinical leadership | *Consultant(s)* | *Towns* | Palliative medicine, pain management and complex system control, advance care planning, service development and clinical leadership, postgraduate medical education, patient safety and risk management |
sex development | *Consultant(s)* | *Towns* | Diabetes, Klinefelter syndrome, congenital adrenal hyperplasia, sex development |
